Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Sell
5,281
-27,120
-84% -$9.28M 0.04% 734
2026
Q1
$11.4M Buy
+32,401
New +$11.6M 0.22% 94
2025
Q4
Sell
-33,221
Closed -$9.37M 1507
2025
Q3
$9.37M Buy
33,221
+16,434
+98% +$4.77M 0.23% 83
2025
Q2
$4.69M Buy
16,787
+7,370
+78% +$2.09M 0.11% 245
2025
Q1
$2.93M Sell
9,417
-6,392
-40% -$1.89M 0.2% 117
2024
Q4
$4.12M Buy
15,809
+13,038
+471% +$3.87M 0.27% 73
2024
Q3
$893K Sell
2,771
-1,756
-39% -$574K 0.05% 497
2024
Q2
$1.41M Buy
+4,527
New +$1.33M 0.08% 357
2024
Q1
Sell
-1,354
Closed -$390K 1333
2023
Q4
$390K Buy
+1,354
New +$369K 0.04% 721
2023
Q3
Sell
-9,600
Closed -$2.13M 1031
2023
Q2
$2.13M Buy
+9,600
New +$2.23M 0.23% 103
2023
Q1
Sell
-10,633
Closed -$2.79M 1154
2022
Q4
$2.79M Buy
+10,633
New +$2.85M 0.41% 23
2022
Q3
Sell
-23,889
Closed -$5.81M 943
2022
Q2
$5.81M Buy
23,889
+17,080
+251% +$4.19M 0.76% 9
2022
Q1
$1.65M Buy
6,809
+1,057
+18% +$243K 0.38% 46
2021
Q4
$1.29M Sell
5,752
-973
-14% -$205K 0.31% 74
2021
Q3
$1.43M Buy
6,725
+2,196
+48% +$505K 0.26% 116
2021
Q2
$1.1M Buy
4,529
+2,201
+95% +$541K 0.28% 79
2021
Q1
$581K Buy
+2,328
New +$555K 0.16% 210

Other funds holding AMGN

Y-Intercept (HK)'s AMGN Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Amgen (AMGN) stake by 84% in Q2 2026, selling an estimated $9.28M and leaving 5,281 shares worth $1.91M. The position accounts for 0.04% of the portfolio, ranked #734.

Y-Intercept (HK) first reported a position in AMGN in Q1 2021 and has held it in 17 quarters since. The position peaked at $11.4M in Q1 2026. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Y-Intercept (HK) held 5,281 shares of Amgen worth $1.91M as of Q2 2026.
  • Y-Intercept (HK) sold 27,120 Amgen shares in Q2 2026, an estimated $9.28M.
  • Amgen made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #734 holding.
  • Y-Intercept (HK) first reported a position in Amgen in Q1 2021 and has held it in 17 quarters since.
  • Y-Intercept (HK)'s Amgen position peaked at $11.4M in Q1 2026.
  • 836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.